GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Innate Pharma IPHA · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.51

+4.86%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Innate Pharma

Our reporting

Past results

Reported against what analysts expected

17 Sept 202613 May 202613 Nov 202513 Nov 202413 May 202414 Sept 2023
Earnings per share-0.24-0.35-0.30-0.34-0.130.02
Forecast-0.29-0.35-0.33-0.30-0.440.09
Revenue$6.5m$4.8m$5.8m$13.6m$23.2m$42.9m
Forecast$6.4m$5.7m$2.3m$13.3m$18.2m$68.6m

Key events

  1. 17 Oct 2019Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.